Accelerate to discover

Back to filter

Related topics

High quality Bioluminescence and X-Ray analysis in lung squamous cell carcinoma

Spectral Instruments Imaging

Jul 21, 2021

Spectral Instruments Imaging provides unrivaled sensitivity for bioluminescence, fluorescence and X-Ray for in vivo...

Webinar recording: Autofluorescence management - the power of Spectral Flow Cytometry

Cytek Biosciences

Jul 15, 2021

One of the key advantages of spectral flow cytometry is its ability to extract sample autofluorescence, making it much...

Top 10 Pharma companies have chosen CYTEK for their flow cytometry facility

Cytek Biosciences

Jul 13, 2021

6 of Top 10 Pharma Companies (Based on total group revenues) have chosen CYTEK - full spectrum flow cytometer for their...

Aug 1, 2021

Introducing IZON Exoid: accurate analysis of nanoparticles from 1 to 1000 nm

IZON

Jul 7, 2021

The IZON Exoid is the only standardisable method of measuring the entire nano range (1–1000 nm).

Webinar recording: Super-Resolution imaging of Chromatin organization in health and disease

ONI

Jul 6, 2021

Understanding how cells organize the array of components within their membranous confines can not only provide insight...

Pretargeted delivery of PI3K/mTOR small-molecule inhibitor–loaded nanoparticles

Spectral Instruments Imaging

Jun 23, 2021

Overactivation of the PI3K/mTOR signaling has been identified in non-Hodgkin’s lymphoma. BEZ235 is an effective dual...

Aug 1, 2021

Microvascular injury in mild traumatic brain injury accelerates alzheimer-like pathogenesis in mice

RWD

Jun 22, 2021

Traumatic brain injury (TBI) is considered as the most robust environmental risk factor for Alzheimer’s disease....

Show all topics (10)

Registering FDG/PET mouse and AMYViD/PET-CT rat studies to brain VOI atlases

May 22, 2018

Preclinical NeuroPET is employed widely in studies of stroke, ischemia, addiction and neurodegenerative diseases. A wide range of tracers are used in NeuroPET studies. In both clinical and preclinical imaging, 18FDG is frequently used as a biomarker of brain function in models of neurological disorders. Targeted tracers such as the recently FDA approved Florbetapir F18 (AMYViD) amyloid tracer provide specific activity. Additionally, using both post synaptic and pre synaptic specific tracers, researchers can make in vivo measurements of neurotransmitter function.

Do you want to learn more? Read the whole article!

 

 

 

Scientific paper
Application

Related technologies: PET, SPECT, CT | Magnetic resonance imaging

Get more info

Miroslav Vecheta

Support specialist

Miroslav

Vecheta

+420 255 700 886

Send Message

Brand profile

Bruker Biospin

Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.

Related products

Albira combines PET, SPECT and CT imaging in a unique and extremely powerful way

show detail

MRI and PET imaging combined for the best of both worlds

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey